Professor Kieron Dunleavy is a Professor of Medicine, Director of the Lymphoma Program and Co-Director of the Microbial Oncology Program in the Division of Hematology & Oncology at The George Washington University Cancer Center, Washington, US. Prof. Dunleavy was educated at University College Dublin, Dublin, IE, and subsequently at the National Cancer Institute (NCI), Bethesda, US. Following his fellowship at the NCI, he remained on staff as an attending physician and has been the Clinical Director of the Lymphoid Malignancies Branch at the NCI. Prof. Dunleavy’s work to date has focused on the biology and treatment of lymphoid diseases. His interests include aggressive and indolent lymphomas, as well as virus-associated and microbe-associated lymphoid diseases, such as those associated with EBV and HIV. He serves on the scientific advisory board of the Lymphoma Research Foundation and on the editorial board of several journals, including Haematologica, Blood, and Leukemia & Lymphoma. Prof. Dunleavy has published over 100 manuscripts and textbook chapters and frequently presents his work nationally and internationally.